Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In SituE. Shelley Hwang, Doreen M. Agnese, Meredith Witten et al.|JAMA|2024Cited by 75
Evaluation of a National Quality Improvement Collaborative for Improving Cancer ScreeningRachel Hae‐Soo Joung, Julian K. Berrocal, Timothy W. Mullett et al.|JAMA Network Open|2022Cited by 28
Patient-Reported Outcomes for Low-Risk Ductal Carcinoma In SituAnn H. Partridge, Kimberly Strickland, Terry Hyslop et al.|JAMA Oncology|2024Cited by 16